Zidovudine resistance of human immunodeficiency virus

Reviews of Infectious Diseases

Volumn 12, Issue , 1990, Pages S507-S512

  Richman, Douglas D ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIDANOSINE; FOSCARNET; RNA DIRECTED DNA POLYMERASE; STAVUDINE; ZALCITABINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AIDS RELATED COMPLEX; CELL CULTURE; CLINICAL ARTICLE; CONFERENCE PAPER; CROSS RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MUTANT; PRIORITY JOURNAL; VIRUS ISOLATION; VIRUS PLAQUE; VIRUS RESISTANCE;

CELLS, CULTURED; DRUG RESISTANCE, MICROBIAL; HIV; HIV INFECTIONS; HUMAN; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.; ZIDOVUDINE;

EID: 0025293462     PISSN: 01620886     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/12.Supplement_5.S507     Document Type: Article

References (11)

1. Larder BA, Darby G. Virus drug-resistance: mechanisms and consequences. Antiviral Res 1984;4:1–42
2. Barry DW, Nusinoff-Lehrman S, Ellis MN, Biron KK, Furman PA. Viral resistance, clinical experience. Scand J Infect Dis Suppl 1985; 47:155–64
3. Erice A, Chou S, Biron KK, Stanat SC, Balfour HH Jr, Jordan MC. Progressive disease due to ganciclovir-resistant cytomegalovirus in immunocompromised patients. N Engl J Med 1989;320:289–92
4. Erlich KS, Mills J, Chatis P, Mertz OJ, Busch DF, Follansbee SE, Grant RM, Crumpacker CS. Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome. N Engl J Med 1989;320: 293–6
5. Belshe RB, Burk B, Newman F, Cerruti RL, Sim IS. Resistance of influenza A virus to amantadine and rimantadine: results of one decade of surveillance. J Infect Dis 1989;159:430–5
6. Fischl MA, Richman DD, Causey DM, Grieco MH, Bryson Y, Mildvan D, Laskin OL, Groopman JE, Volberding PA, Schooley RT, Jackson GG, Durack DT, Andrews JC, Nusinoff-Lehrman S, Barry DW, the AZT Collaborative Working Group. Prolonged zidovudine therapy in patients with AIDS and advanced AIDS-related complex. JAMA 1989;262:2405–10
7. Larder BA, Darby G, Richman DD. HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy. Science 1989;243:1731–4
8. Larder BA, Chesebro B, Richman DD. Susceptibilities of zidovudine-susceptible and -resistant human immunodeficiency virus isolates to antiviral agents determined by using a quantitative plaque reduction assay. Antimicrob Agents Chemother 1990;34:436–41
9. Chesebro B, Wehrly K. Development of a sensitive quantitative focal assay for human immunodeficiency virus infec- tivity. J Virol 1988;62:3779–88
10. Larder BA, Kemp SD. Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT). Science 1989;246:1155–8
11. Mosier DE, Gulizia RJ, Baird SM, Wilson DB. Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 1988;335:256–9